Virtual Library
Start Your Search
George Blumenschein
Moderator of
-
+
04 - TRK, ROS1 and ALK (ID 04)
- Event: TTLC 2019
- Type: General Session
- Track:
- Presentations: 11
- Moderators:George Blumenschein, Peter Ujhazy
- Coordinates: 2/21/2019, 10:05 - 11:10, Starlight Ballroom
-
+
Alectinib (ALK) (ID 04.06)
10:05 - 11:10 | Author(s): Shirish Gadgeel
- Abstract
Abstract not provided
-
+
Brigatinib First Line (ALK) (ID 04.07)
10:05 - 11:10 | Author(s): Ross Camidge
- Abstract
Abstract not provided
-
+
Brigatinib Following 2nd Generation ALK TKI (ID 04.10)
10:05 - 11:10 | Author(s): Thomas Stinchcombe
- Abstract
Abstract not provided
-
+
Crizotinib (ALK, ROS1) (ID 04.04)
10:05 - 11:10 | Author(s): Jessica Lin
- Abstract
Abstract not provided
-
+
Ensartinib (ALK) (ID 04.08)
10:05 - 11:10 | Author(s): Leora Horn
- Abstract
Abstract not provided
-
+
Entrectinib (TRK, ROS1) (ID 04.01)
10:05 - 11:10 | Author(s): Robert Doebele
- Abstract
Abstract not provided
-
+
Larotrectinib (Loxo101) (TRK) (ID 04.05)
10:05 - 11:10 | Author(s): Anna Farago
- Abstract
Abstract not provided
-
+
Lorlatinib (ALK, ROS1) (ID 04.09)
10:05 - 11:10 | Author(s): Alice Shaw
- Abstract
Abstract not provided
-
+
Loxo 195 (TRK) (ID 04.03)
10:05 - 11:10 | Author(s): Alexander Drilon
- Abstract
Abstract not provided
-
+
TPX005 (TRK, ROS1) (ID 04.02)
10:05 - 11:10 | Author(s): Ignatius Ou
- Abstract
Abstract not provided
-
+
Where Do We Go From Here? (ID 04.11)
10:05 - 11:10 | Author(s): Christine Lovly
- Abstract
Abstract not provided
-
+
18 - MET/RET (ID 18)
- Event: TTLC 2019
- Type: General Session
- Track:
- Presentations: 14
- Moderators:George Blumenschein, Travis Osterman
- Coordinates: 2/22/2019, 16:40 - 18:00, Starlight Ballroom
-
+
BLU667 (RET) (ID 18.01)
16:40 - 18:00 | Author(s): Justin Gainor
- Abstract
Abstract not provided
-
+
Cabozantinib (MET) (ID 18.08)
16:40 - 18:00 | Author(s): Joel Neal
- Abstract
Abstract not provided
-
+
Capmatinib (MET) (ID 18.06)
16:40 - 18:00 | Author(s): Rebecca Heist
- Abstract
Abstract not provided
-
+
Crizotinib (MET) (ID 18.05)
16:40 - 18:00 | Author(s): Mark Kris
- Abstract
Abstract not provided
-
+
Emibetuzumab (MET) (ID 18.10)
16:40 - 18:00 | Author(s): Ron Natale
- Abstract
Abstract not provided
-
+
Loxo 292 (RET) (ID 18.03)
16:40 - 18:00 | Author(s): Alexander Drilon
- Abstract
Abstract not provided
-
+
Merestinib (AXL) (ID 18.13)
16:40 - 18:00 | Author(s): Mark Awad
- Abstract
Abstract not provided
-
+
Multi TKIs (Cabo, Levantinib, Alectinib, Ponatinib) (RET) (ID 18.04)
16:40 - 18:00 | Author(s): Adrian Sacher
- Abstract
Abstract not provided
-
+
RXDX104/015 (RET) (ID 18.02)
16:40 - 18:00 | Author(s): Jyoti Patel
- Abstract
Abstract not provided
-
+
Savolitinib (MET) (ID 18.09)
16:40 - 18:00 | Author(s): Mark Awad
- Abstract
Abstract not provided
-
+
Science (ID 18.14)
16:40 - 18:00 | Author(s): Trever Bivona
- Abstract
Abstract not provided
-
+
Sym015 (MET) (ID 18.11)
16:40 - 18:00 | Author(s): Ross Camidge
- Abstract
Abstract not provided
-
+
Tepotinib (MET) (ID 18.07)
16:40 - 18:00 | Author(s): Xiuning Le
- Abstract
Abstract not provided
-
+
TPX0022 (MET) (ID 18.12)
16:40 - 18:00 | Author(s): Joel Neal
- Abstract
Abstract not provided